MedPath

Progression to Impaired Glucose Tolerance and Type 2 Diabetes in the Korean People-based KNDP Study

Completed
Conditions
Impaired Glucose Tolerance
Diabetes
Registration Number
NCT01034826
Lead Sponsor
Korea University Guro Hospital
Brief Summary

Impaired glucose tolerance is a metabolic state between normal glucose homeostasis and diabetes. Previously, prospective studies have shown higher progression rates from IGT to diabetes in other country. But There is no prospective-multicenter based reports in Korea. Therefore, the purpose of this study is to estimate the progression rates to impair glucose regulation and diabetes in the Korean population-based Korea national Diabetes program.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
500
Inclusion Criteria
  • fastic serum glucose >100 and/or pp2 serum glucose <200
Read More
Exclusion Criteria
  • known diabetes
  • organ failure(For example, liver, kidney)
  • known malignancy
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
fasting serum glucose, fasting plasma insulin,post prandial serum glucose, post prandial plasma insulin, hbA1c0.1.3.5 year
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath